As to NSCLC, it was also elucidated in previous research that the PAX-ZEB2 axis could mediate metastasis and cisplatin resistance via the PI3K-Akt pathway, though the relationship between PI3K-Akt and ZEB2 was not fully clarified[75]. The gene discussed is ZEB2; the disease is non-small cell lung carcinoma.